• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CAM与κ阿片受体激动剂的阿片样物质活性比较。

Comparison of the opioid activity of CAM and kappa agonists.

作者信息

Furst S, Friedmann T, Kovacs A, Wagner T

机构信息

Department of Pharmacology, Semmelweis University of Medicine, Budapest, Hungary.

出版信息

NIDA Res Monogr. 1986;75:224-7.

PMID:2828975
Abstract

CAM has been shown to produce opiate agonist and antagonist activities. Based on its potent agonist activity in rabbit vas deferens and the low potency of naloxone to antagonize its agonist effect in the guinea pig ileum and mouse vas deferens, CAM can be considered as kappa agonist. It is further supported by its diuretic effect and the estimated "apparent pA2" values with naloxone and Mr-2266BS. However, in the rabbit ear artery and cat nictitating membrane, ethylketazocine (EK) produced agonist activity, while CAM produced antagonist activity. Also, EK differs from CAM in mouse vas deferens in the presence of 4-aminopyridine. It is concluded, that CAM might be an agonist on kappa type (subtype) of opiate receptors, although its spectrum of activity was found to be different from EK or bremazocine.

摘要

已证明骆驼蓬碱具有阿片激动剂和拮抗剂活性。基于其在兔输精管中的强效激动剂活性以及纳洛酮在豚鼠回肠和小鼠输精管中拮抗其激动剂作用的低效性,骆驼蓬碱可被视为κ激动剂。其利尿作用以及与纳洛酮和Mr - 2266BS的估计“表观pA2”值进一步支持了这一点。然而,在兔耳动脉和猫瞬膜中,乙基酮佐辛(EK)产生激动剂活性,而骆驼蓬碱产生拮抗剂活性。此外,在存在4 - 氨基吡啶的情况下,EK在小鼠输精管中的作用与骆驼蓬碱不同。得出的结论是,骆驼蓬碱可能是阿片受体κ型(亚型)的激动剂,尽管发现其活性谱与EK或布马佐辛不同。

相似文献

1
Comparison of the opioid activity of CAM and kappa agonists.CAM与κ阿片受体激动剂的阿片样物质活性比较。
NIDA Res Monogr. 1986;75:224-7.
2
Further study of kappa opioids on increased urination.对κ阿片类药物增加排尿作用的进一步研究。
J Pharmacol Exp Ther. 1983 Oct;227(1):35-41.
3
Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.强啡肽-(1-13)作为阿片κ受体激动剂的证据。
Eur J Pharmacol. 1982 Jan 22;77(2-3):137-41. doi: 10.1016/0014-2999(82)90008-5.
4
Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.κ激动剂诱导的利尿作用:立体选择性、品系差异、水合变量独立性及血浆血管加压素水平降低结果的证据
J Pharmacol Exp Ther. 1987 Jul;242(1):33-9.
5
The choice of opiate receptor subtype by neo-endorphins.新内啡肽对阿片受体亚型的选择。
Eur J Pharmacol. 1982 Apr 23;79(3-4):301-5. doi: 10.1016/0014-2999(82)90636-7.
6
Place-conditioning properties of mu, kappa, and sigma opioid agonists.μ、κ和σ阿片样物质激动剂的位置条件反射特性。
Alcohol Drug Res. 1985;6(5):327-39.
7
Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations.丁丙诺啡对离体标本中三种阿片受体的激动和拮抗作用。
Jpn J Pharmacol. 1986 Jan;40(1):95-101. doi: 10.1254/jjp.40.95.
8
Delta and kappa opioid receptors in the rabbit ear artery.兔耳动脉中的δ和κ阿片受体
NIDA Res Monogr. 1986;75:105-8.
9
Opioid receptors in the mouse ileum.小鼠回肠中的阿片受体。
Arch Int Pharmacodyn Ther. 1988 Jan-Feb;291:122-31.
10
Profile of activity of kappa receptor agonists in the rabbit vas deferens.κ受体激动剂在兔输精管中的活性概况
Eur J Pharmacol. 1985 Apr 16;110(3):317-22. doi: 10.1016/0014-2999(85)90558-8.